Democratic Underground Latest Greatest Lobby Journals Search Options Help Login
Google

FDA review spotlights heart risk of diabetes pill Avandia

Printer-friendly format Printer-friendly format
Printer-friendly format Email this thread to a friend
Printer-friendly format Bookmark this thread
This topic is archived.
Home » Discuss » Latest Breaking News Donate to DU
 
Bozita Donating Member (1000+ posts) Send PM | Profile | Ignore Fri Jul-09-10 12:14 PM
Original message
FDA review spotlights heart risk of diabetes pill Avandia
Edited on Fri Jul-09-10 12:24 PM by Bozita
Source: AP

Last Updated: July 09. 2010 11:30AM
FDA review spotlights heart risk of diabetes pill Avandia
Matthew Perrone / Associated Press

Washington -- A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug.

The FDA posted an exhaustive 700-page review of the GlaxoSmithKline drug online Friday ahead of a meeting next week to review the safety of Avandia, which is used by hundreds of thousands of diabetics in the U.S.

The FDA holds a special two-day meeting starting Tuesday to help decide what course of action to take. A panel of outside expert physicians will vote on a range of recommendations for Avandia including:
• adding additional warning labels
• limiting which doctors can prescribe the drug
• pulling the drug from the market

The FDA is not required to follow the advice of its outside panels, though it usually does.

Read more: http://www.detnews.com/article/20100709/LIFESTYLE03/7090423/1361/FDA-review-spotlights-heart-risk-of-diabetes-pill-Avandia#ixzz0tCprvK3v



Here's the NYT piece on the same topic:



F.D.A. Disputes Finding That Avandia Is Safe
By GARDINER HARRIS
Published: July 9, 2010


WASHINGTON — The drug maker GlaxoSmithKline misinterpreted crucial details of a study finding that Avandia, its blockbuster diabetes drug, is safe, a medical reviewer for the Food and Drug Administration said Friday.

Correctly interpreted, the study actually supports critics’ contentions that Avandia may cause heart attacks, said the reviewer, Dr. Thomas Marciniak, in a posting on the F.D.A.’s Web site.

The company’s misreadings of the study, known as the Record trial, were so profound, he concluded, that they “suggest serious flaws with trial conduct.”

“One does not have to be a mathematician or to perform calculations,” he wrote, to come to the conclusion that a combined look at all the trials of Avandia would demonstrate that it causes heart attacks.

more ...

http://www.nytimes.com/2010/07/10/health/10diabetes.html?_r=1&hpw
Printer Friendly | Permalink |  | Top
glinda Donating Member (1000+ posts) Send PM | Profile | Ignore Fri Jul-09-10 08:52 PM
Response to Original message
1. Majority of drugs on the market are failures IMHO.
Printer Friendly | Permalink |  | Top
 
DU AdBot (1000+ posts) Click to send private message to this author Click to view 
this author's profile Click to add 
this author to your buddy list Click to add 
this author to your Ignore list Sun Nov 03rd 2024, 07:34 AM
Response to Original message
Advertisements [?]
 Top

Home » Discuss » Latest Breaking News Donate to DU

Powered by DCForum+ Version 1.1 Copyright 1997-2002 DCScripts.com
Software has been extensively modified by the DU administrators


Important Notices: By participating on this discussion board, visitors agree to abide by the rules outlined on our Rules page. Messages posted on the Democratic Underground Discussion Forums are the opinions of the individuals who post them, and do not necessarily represent the opinions of Democratic Underground, LLC.

Home  |  Discussion Forums  |  Journals |  Store  |  Donate

About DU  |  Contact Us  |  Privacy Policy

Got a message for Democratic Underground? Click here to send us a message.

© 2001 - 2011 Democratic Underground, LLC